The table below shows DEXCOM INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$1.19B
$1.21B
$1.16B
$1.04B
$994.20M
$1.00B
Cost of revenue
$441.60M
$477.90M
$468.30M
$447.00M
$400.40M
$377.60M
Gross profit
$750.30M
$731.40M
$688.80M
$589.00M
$593.80M
$626.70M
R&D
$145.30M
$157.50M
$148.20M
$145.20M
$135.40M
$136.00M
DXCM annual revenue (10-K history)
DEXCOM INC reported annual revenue of $4.66B for fiscal year 2025. That is up 15.6% from $4.03B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $573.30M (FY 2016) to $4.66B. Figures come from the company's audited annual reports as filed with the SEC.
